Pandora Report 11.21.2026: Measles Is Back – and America’s Immunization Shield is Slipping

Welcome to this week’s Pandora Report! This issue examines the United States officially losing its measles elimination status for the first time in over 25 years, rising H5N1 avian influenza and New World screwworm outbreaks, and global efforts to strengthen chemical and biological attribution.

Happy Thanksgiving from all of us at The Pandora Report! 🍂 We will be on holiday break next week and will return to your inboxes on Friday, December 4.


The U.S. Just Lost Its Measles Elimination Status. Other Diseases Could Follow.

By Carmen Shaw, Managing Editor, The Pandora Report | PhD Biodefense, GMU

Figure 1. Routine immunization remains the strongest defense against measles. The CDC recommends two doses of the measles-mumps-rubella (MMR) vaccine for all children—at 12–15 months and 4–6 years of age—and at least one dose for unvaccinated adults to prevent measles transmission. (Photo: Gustavo Fring / Pexels).

For the first time in over 25 years, the United States has officially lost its measles elimination status, marking a deeply concerning moment for the nation’s public health system. Under criteria used by the Pan American Health Organization (PAHO), which announced the decision on Tuesday, November 17, maintaining elimination depends on a country’s ability to interrupt sporadic outbreaks within a year. Sustained transmission across multiple U.S. states has now breached that threshold. “We are seeing a resurgence of a disease our region worked so hard to eliminate,” PAHO Director Jarbas Barbosa said at a press briefing. In the past two years alone, measles has sickened more than 8,000 Americans, hospitalized over 830, and imposed roughly $130 million in medical care, public health response, and lost productivity, according to Johns Hopkins University researchers. States have also reported 13 measles-associated deaths, including a 7-month-old in New York and infants in Pennsylvania and Wisconsin – children who are too young to even receive the routine two-dose measles-mumps-rubella (MMR) vaccine, which is typically given starting at age one.

Childhood vaccination rates have steadily declined since the COVID-19 pandemic began, a trend many scientists say has been compounded by the Trump administration for spreading vaccine misinformation, cutting millions of dollars from state-run children’s immunization programs and terminating research funding on vaccine hesitancy. “Measles causes so much unnecessary suffering, everything from a high fever and missed work and school to long-term complications like progressive nerve disease and death,” noted epidemiologist and former CDC Deputy Director, Anne Schuchat. Yet, measles outbreaks are entirely preventable: Two doses of the MMR vaccine prevent about 97% of infections, so when almost everyone in a community is fully vaccinated, the virus cannot spread.

Beyond its immediate human and economic toll, measles serves as a kind of epidemiological “canary in the coal mine” for broader domestic health security vulnerabilities. Because the virus is exceptionally contagious, it is typically the first pathogen to reemerge when routine immunization rates drop, signaling heightened risk for parallel resurgences of pertussis (whooping cough), mumps, and rubella, underscoring that regaining elimination status will require years of sustained investment in public health infrastructure and working to restore community trust in science.

Further Reading:


WOAH Urges Vigilance as Bird Flu Outbreaks Rise

By Margeaux Malone, Pandora Report Associate Editor

On November 16, the World Organisation for Animal Health (WOAH) called for heightened vigilance after reports indicated that outbreaks of high pathogenicity avian influenza H5N1 (HPAI) rose over the past three weeks in both poultry and wild birds. Drawing on data submitted through its World Animal Health Information System, WOAH stressed that the increase does not establish a global resurgence or forecast what the season has in store but is a signal for countries to review their preparedness, early detection, and response measures.

Over the past 15 years, reports have shown a recurring seasonal pattern, with Northern Hemisphere outbreaks generally starting to rise in October and peaking around February. Timing and severity vary by year and region, shaped by wild bird movements, farm biosecurity and animal movements. The organization highlighted that surveillance in wild birds can provide early warning, sometimes before outbreaks reach poultry farms. It is members to strengthen surveillance across poultry, wild birds and other susceptible animals, including mammals; reinforce biosecurity by preventing contact between poultry and wild birds and controlling access by people, vehicles and equipment; make reporting clear and accessible for farmers, veterinarians and wildlife workers; check the readiness of laboratories and veterinary services; and share information transparently.

Meanwhile, the U.S. continues to report new H5N1 outbreaks including confirmation of a case in an Oklahoma dairy herd, the state’s first since July 2024. On Wednesday November 18, Cal-Maine Foods, the nation’s largest egg producer, announced it will cull 1.8 million birds, about 2.7 percent of its flock, after detecting the virus at a Florida facility.

Screwworm spreads in the Southwest

Although the upcoming winter season is predicted to temporarily slow New World screwworm activity, outbreaks of the parasite have accelerated in recent weeks. The U.S. Department of Agriculture reports 139 confirmed animal infestations since June across Texas, New Mexico and Arizona. Since November first, cases have risen about 76% from 79 to 139 with new infestations reaching Goliad County, Texas, and Pima County, Arizona. Animal movement is restricted in infested zones, and owners are urged to inspect animals regularly and report unusual wounds. No U.S. human cases have been reported, though Mexico and Central America have recorded more than 2,850.

Further Reading:


IN OTHER NEWS

Chemical Weapons Use, Biological Attribution, and Accountability

AI, Biotechnology, and Biosecurity Innovation

Infectious Disease Outbreaks and Global Health

NEW: United States Measles Elimination Status: The Current Landscape and Path Toward Prevention – Congressional Briefing and Webinar

Wednesday, December 9 | 1:00 PM ET

For the first time in over 25 years, the United States is no longer considered to have eliminated measles. This unfortunate milestone shows that the U.S. is losing ground in measles prevention and control, causing unnecessary suffering for families and communities. Join the Association for Immunization Managers, Infectious Disease Society of America (IDSA), Trust for America’s Health, and Vaccinate Your Family for a congressional briefing and webinar explaining the Pan American Health Organization’s measles elimination status review process and implications for the country.

Link to register

Canadian Biosafety Guidelines: Risk Management for Dual-Use Potential in Life Science Research – Webinar

Thursday, November 26 | 1:00 – 2:00 pm ET

From the Public Health Agency of Canada: “Life science research drives breakthroughs that benefit society, but how can organizations and researchers ensure those advances are pursued responsibly? Join the Centre for Biosecurity for an upcoming webinar to learn about the new Canadian Biosecurity Guideline on Risk Management for Dual-Use Potential in Life Science Research. Participants will gain an overview of the newly published guideline, learn the importance of dual-use risk management, and explore practical approaches for identifying, assessing, and mitigating associated risks.”

Link to register

Gordon Research Seminar (GRS) on Chemical and Biological Defense

Saturday, February 27 – Sunday, February, 2027 | Ventura, CA

Held directly before the main Gordon Research Conference (see below), this two-day seminar, “Integrated Response Strategies for Complex Threats in Chemical and Biological Defense,” provides a unique forum for early-career researchers, doctoral students, and postdocs to present original work, discuss emerging threats, and build professional networks. Key topics include threat detection, characterization, and convergent approaches spanning in silico, in vitro, and in vivo models. The program features oral presentations, poster sessions, and a mentorship panel on “Career Pathways and Perspectives in Chemical and Biological Defense.” Abstract submission deadline for talk consideration is November 22, 2026; general applications close January 30, 2027.

Link to apply

Gordon Research Conference (GRC) on Chemical and Biological Defense

Sunday, February 28 – Friday, March 5, 2027 | Ventura, CA

Join international researchers, policy leaders, and scientists for a Gordon Research Conference, “The Convergence of In Silico, In Vitro, and In Vivo Models to Address the Divergent and Intersecting Profiles of Chemical and Biological Threats.” This five-day premier conference focuses on cutting-edge research in chemical and biological defense. Session topics include AI-accelerated science, agent-agnostic threat detection, attribution of CBRN events, medical countermeasure design, and biosecurity policy governance. Applications are due by January 31, 2027.

Link to apply

Leave a Reply